Intensive Induction Chemotherapy Vs Hypomethylating Agents + Venetoclax (HMA/VEN) in NPM1-Mutant Newly Diagnosed Acute Myeloid Leukemia (AML) - a Multicenter Cohort Study

Introduction: Intensive induction chemotherapy (IC) with cytarabine + anthracycline remains the standard of care for younger and fit patients (pts) with acute myeloid leukemia (AML). Post-hoc analyses from clinical trials evaluating venetoclax (VEN)-based therapies in AML have identified mutations i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2964-2964
Hauptverfasser:	Bewersdorf, Jan Philipp, Shimony, Shai, Shallis, Rory M., Liu, Yiwen, Schaefer, Eva Johanna, Zeidan, Amer M., Goldberg, Aaron D., Stein, Eytan M., Marcucci, Guido, Lindsley, R. Coleman, Chen, Evan C., Ramos, Jorge, Stein, Anthony Selwyn, DeAngelo, Daniel J., Neuberg, Donna S., Stone, Richard M, Ball, Brian J., Stahl, Maximilian
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!